Terms: = Lung cancer AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Prognosis
160 results:
1. Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection.
Jiang MQ; Qian LQ; Shen YJ; Fu YY; Feng W; Ding ZP; Han YC; Fu XL
Neoplasia; 2024 Apr; 50():100979. PubMed ID: 38387107
[TBL] [Abstract] [Full Text] [Related]
2. Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma.
de Miguel-Perez D; Pickering EM; Malapelle U; Grier W; Pepe F; Pisapia P; Russo G; Pinto JA; Russo A; Troncone G; Culligan MJ; Scilla KA; Mehra R; Mohindra P; Arrieta O; Cardona AF; Del Re M; Sachdeva A; Hirsch FR; Wolf A; Friedberg JS; Rolfo C
Eur J Cancer; 2024 Jan; 196():113457. PubMed ID: 38008032
[TBL] [Abstract] [Full Text] [Related]
3. Pulmonary Low Malignant Potential Adenocarcinoma: A Validation of the Proposed Criteria for This Novel Subtype.
Pittaro A; Crivelli F; Orlando G; Napoli F; Zambelli V; Guerrera F; Sobrero S; Volante M; Righi L; Papotti M
Am J Surg Pathol; 2024 Feb; 48(2):204-211. PubMed ID: 37981865
[TBL] [Abstract] [Full Text] [Related]
4. BATF2 inhibits PD-L1 expression and regulates CD8+ T-cell infiltration in non-small cell lung cancer.
Liu J; Li J; Tuo Z; Hu W; Liu J
J Biol Chem; 2023 Nov; 299(11):105302. PubMed ID: 37777155
[TBL] [Abstract] [Full Text] [Related]
5. Automated CT quantification of interstitial lung abnormality and interstitial lung disease according to the Fleischner Society in patients with resectable lung cancer: prognostic significance.
Ahn Y; Lee SM; Choi S; Lee JS; Choe J; Do KH; Seo JB
Eur Radiol; 2023 Nov; 33(11):8251-8262. PubMed ID: 37266656
[TBL] [Abstract] [Full Text] [Related]
6. Upfront Use of First-/Second-Generation EGFR-TKI Followed by Osimertinib Shows Better prognosis than Upfront Osimertinib Therapy in Japanese Patients with Non-small-cell lung cancer with Exon 19 Deletion: A Single-Center Retrospective Study.
Hori T; Yamamoto K; Ito T; Ikushima S; Omura T; Yano I
Biol Pharm Bull; 2023; 46(6):788-795. PubMed ID: 37258143
[TBL] [Abstract] [Full Text] [Related]
7. Regulation of early diagnosis and prognostic markers of lung adenocarcinoma in immunity and hypoxia.
Sun K; Zhang Z; Wang D; Huang Y; Zhang J; Lian C
Sci Rep; 2023 Apr; 13(1):6459. PubMed ID: 37081097
[TBL] [Abstract] [Full Text] [Related]
8. Real-world treatment pattern and prognostic factors of stage IV lung squamous cell carcinoma patients.
Hsu EC; Wu KL; Tsai YM; Lee MH; Tsai MJ; Kuo CY; Liu YC; Liang FW; Yang CJ; Hung JY
Kaohsiung J Med Sci; 2022 Oct; 38(10):1001-1011. PubMed ID: 36214468
[TBL] [Abstract] [Full Text] [Related]
9. Medical Data Analysis of CYP1B1 Gene Polymorphism and Clinical prognosis of Minimally Invasive Surgery for lung cancer.
Han X; Li D; Zhang S
Biomed Res Int; 2022; 2022():5217625. PubMed ID: 36193313
[TBL] [Abstract] [Full Text] [Related]
10. Genetic predisposition to lung adenocarcinoma outcome is a feature already present in patients' noninvolved lung tissue.
Minnai F; Noci S; Chierici M; Cotroneo CE; Bartolini B; Incarbone M; Tosi D; Mattioni G; Jurman G; Dragani TA; Colombo F
Cancer Sci; 2023 Jan; 114(1):281-294. PubMed ID: 36114746
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of complex glandular patterns in invasive pulmonary adenocarcinomas.
Bossé Y; Gagné A; Althakfi W; Orain M; Fiset PO; Desmeules P; Joubert P
Hum Pathol; 2022 Oct; 128():56-68. PubMed ID: 35872155
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer.
Matsumoto Y; Kawaguchi T; Watanabe M; Isa SI; Ando M; Tamiya A; Kubo A; Kitagawa C; Yoshimoto N; Koh Y
BMC Cancer; 2022 Jul; 22(1):775. PubMed ID: 35840951
[TBL] [Abstract] [Full Text] [Related]
13. Spatiotemporal genomic analysis reveals distinct molecular features in recurrent stage I non-small cell lung cancers.
Chen K; Yang A; Carbone DP; Kanu N; Liu K; Wang R; Nie Y; Shen H; Bai J; Wu L; Li H; Shi Y; Mok T; Yu J; Yang F; Wu S; Jamal-Hanjani M; Wang J
Cell Rep; 2022 Jul; 40(2):111047. PubMed ID: 35830809
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of clinical results between high grade patterns in stage I lung adenocarcinoma.
Jeon HW; Kim YD; Sim SB; Moon MH
Thorac Cancer; 2022 Sep; 13(17):2473-2479. PubMed ID: 35820717
[TBL] [Abstract] [Full Text] [Related]
15. Role of fluorodeoxyglucose-positron emission tomography in predicting the pathological response and prognosis after neoadjuvant chemoradiotherapy for locally advanced non-small-cell lung cancer.
Tanahashi M; Suzuki E; Yoshii N; Watanabe T; Tsuchida H; Yobita S; Iguchi K; Uchiyama S; Nakamura M
Interact Cardiovasc Thorac Surg; 2022 Jul; 35(2):. PubMed ID: 35543472
[TBL] [Abstract] [Full Text] [Related]
16. Identification of filigree pattern increases the diagnostic accuracy of micropapillary pattern on frozen section for lung adenocarcinoma.
Zhao S; Xie H; Su H; Xu L; Hu X; Zhao D; Zhu E; Xie X; Zhang L; Hou L; Zhang W; Wu C; Chen C;
Histopathology; 2022 Jul; 81(1):119-127. PubMed ID: 35486499
[TBL] [Abstract] [Full Text] [Related]
17. Autophagopathies: from autophagy gene polymorphisms to precision medicine for human diseases.
Grosjean I; Roméo B; Domdom MA; Belaid A; D'Andréa G; Guillot N; Gherardi RK; Gal J; Milano G; Marquette CH; Hung RJ; Landi MT; Han Y; Brest P; Von Bergen M; Klionsky DJ; Amos CI; Hofman P; Mograbi B
Autophagy; 2022 Nov; 18(11):2519-2536. PubMed ID: 35383530
[TBL] [Abstract] [Full Text] [Related]
18. First-line Afatinib in Patients With Non-small-cell lung cancer With Uncommon EGFR Mutations in South Korea.
Kim MH; Choi CM; Lee SY; Park CK; Chang YS; Lee KY; Kim SJ; Yang SH; Ryu JS; Lee JE; Lee SY; Park CK; Lee SH; Jang SH; Yoon SH; Jang TW
Anticancer Res; 2022 Mar; 42(3):1615-1622. PubMed ID: 35220259
[TBL] [Abstract] [Full Text] [Related]
19. Clinical Implication of Borderline CT-Morphological Metastatic Spread in Bladder cancer: What You See Is Not Always What You Got.
Weinhold P; Jokisch F; Schulz GB; Buchner A; Kazmierczak PM; Kretschmer A; Schlenker B; Karl A; Stief CG; Grimm T
Urol Int; 2022; 106(8):806-815. PubMed ID: 35114679
[TBL] [Abstract] [Full Text] [Related]
20. Collagen XI alpha 1 chain, a potential therapeutic target for cancer.
Liu Z; Lai J; Jiang H; Ma C; Huang H
FASEB J; 2021 Jun; 35(6):e21603. PubMed ID: 33999448
[TBL] [Abstract] [Full Text] [Related]
[Next]
